Skip to content
10-Q

Quarterly Report

GW PHARMACEUTICALS PLC

0001564590-20-050655

← back to feed
Filed
Nov 5, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 29, 2020 374.18M sh
Shares Diluted Q3 2020 · Sep 30, 2020 376.28M sh
Shares Diluted Q3 2020 · Sep 30, 2020 375.22M sh
Shares Diluted Q3 2020 · Sep 30, 2019 372.25M sh
Shares Diluted Q3 2020 · Sep 30, 2019 376.99M sh
Capex Q3 2020 · Sep 30, 2020 $14.26M
Capex Q3 2020 · Sep 30, 2019 $29.92M
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$33.31M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$107.52M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $480.33M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $536.93M
Stockholders Equity Q3 2020 · Sep 30, 2020 $734.45M
Stockholders Equity Q3 2020 · Jun 30, 2020 $716.94M
Stockholders Equity Q3 2020 · Mar 31, 2020 $715.01M
Stockholders Equity Q3 2020 · Dec 31, 2019 $726.03M
Stockholders Equity Q3 2020 · Sep 30, 2019 $719.66M
Stockholders Equity Q3 2020 · Jun 30, 2019 $728.89M
Stockholders Equity Q3 2020 · Mar 31, 2019 $639.73M
Stockholders Equity Q3 2020 · Dec 31, 2018 $674.08M
Current Liabilities Q3 2020 · Sep 30, 2020 $140.29M
Current Liabilities Q3 2020 · Dec 31, 2019 $117.56M
Total Liabilities Q3 2020 · Sep 30, 2020 $175.81M
Total Liabilities Q3 2020 · Dec 31, 2019 $156.22M
Current Assets Q3 2020 · Sep 30, 2020 $720.28M
Current Assets Q3 2020 · Dec 31, 2019 $699.64M
Total Assets Q3 2020 · Sep 30, 2020 $910.26M
Total Assets Q3 2020 · Dec 31, 2019 $882.25M
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.03
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.08
Eps Diluted Q3 2020 · Sep 30, 2019 −$0.04
Eps Diluted Q3 2020 · Sep 30, 2019 $0.04
Eps Basic Q3 2020 · Sep 30, 2020 −$0.03
Eps Basic Q3 2020 · Sep 30, 2020 −$0.08
Eps Basic Q3 2020 · Sep 30, 2019 −$0.04
Eps Basic Q3 2020 · Sep 30, 2019 $0.04
Sga Expense Q3 2020 · Sep 30, 2020 $85.21M
Sga Expense Q3 2020 · Sep 30, 2020 $232.28M
Sga Expense Q3 2020 · Sep 30, 2019 $64.18M
Sga Expense Q3 2020 · Sep 30, 2019 $181.53M
Rd Expense Q3 2020 · Sep 30, 2020 $56.93M
Rd Expense Q3 2020 · Sep 30, 2020 $148.54M
Rd Expense Q3 2020 · Sep 30, 2019 $36.3M
Rd Expense Q3 2020 · Sep 30, 2019 $99.14M
Net Income Q3 2020 · Sep 30, 2020 −$12.19M
Net Income Q3 2020 · Sep 30, 2020 −$28.98M
Net Income Q3 2020 · Jun 30, 2020 −$8.83M
Net Income Q3 2020 · Mar 31, 2020 −$7.97M
Net Income Q3 2020 · Sep 30, 2019 −$13.76M
Net Income Q3 2020 · Sep 30, 2019 $15.93M
Net Income Q3 2020 · Jun 30, 2019 $79.75M
Net Income Q3 2020 · Mar 31, 2019 −$50.06M
Operating Income Q3 2020 · Sep 30, 2020 −$12.72M
Operating Income Q3 2020 · Sep 30, 2020 −$28.95M
Operating Income Q3 2020 · Sep 30, 2019 −$17.66M
Operating Income Q3 2020 · Sep 30, 2019 −$98.32M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $7.64M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $27.11M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $8.15M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $19.9M
Revenue Q3 2020 · Sep 30, 2020 $137.05M
Revenue Q3 2020 · Sep 30, 2020 $378.98M
Revenue Q3 2020 · Sep 30, 2019 $90.97M
Revenue Q3 2020 · Sep 30, 2019 $202.26M